Suchergebnisse - "Fares, Aline"

PubPharm (26)

1

Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC-RELANCE/LACOG 0118

enthalten in: JTO clinical and research reports | 2024

von Cordeiro de Lima, V. | Gelatti, A. | Moura, J. | +20

2

Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival : a retrospective, pooled analysis of cohort studies

enthalten in: The Lancet. Public health | 2023

von Fares, A. | Li, Y. | Jiang, M. | +52

CommentIn: Lancet Public Health. 2023 Sep;8(9):e664-e665. - PMID 37633673

3

Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival : a retrospective, pooled analysis of cohort studies

enthalten in: The lancet. Public health | September 2023

von Fares, A. | Li, Y. | Jiang, M. | +52

4

Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma

enthalten in: Esophagus : official journal of the Japan Esophageal Society | 2023

von Zeuge, U. | Fares, A. | Soriano, J. | +14

5

Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma

enthalten in: Esophagus | 2023

von Zeuge, U. | Fares, A. | Soriano, J. | +14

6

Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma

enthalten in: Esophagus | 2023

von Zeuge, U. | Fares, A. | Soriano, J. | +14

7

KuLGaP: A Selective Measure for Assessing Therapy Response in Patient-Derived Xenografts

enthalten in: bioRxiv.org | 2022

von Ortmann, J. | Rampášek, L. | Tai, E. | +20

8

Assessing Oncologists' Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil

enthalten in: JTO clinical and research reports | 2022

von Fares, A. | Martinez, P. | Farina, P. | +14

9

Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers : Examples Based on the International Lung Cancer Consortium Data

enthalten in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 2022

von Schmid, S. | Jiang, M. | Brown, M. | +54

10

Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC : Safety and Efficacy

enthalten in: JTO clinical and research reports | 2021

von Lau, S. | Ryan, M. | Weiss, J. | +18